凯龙股份(002783) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 686,973,446.60, representing a 29.14% increase compared to CNY 531,957,921.69 in the same period last year[3] - Net profit attributable to shareholders reached CNY 65,743,855.86, a significant increase of 1,156.04% from a loss of CNY 6,225,502.40 in the previous year[3] - Basic earnings per share improved to CNY 0.17, compared to a loss of CNY 0.02 per share in the previous year, marking a 950.00% increase[3] - Net profit for Q1 2022 was CNY 70,975,199.66, a turnaround from a net loss of CNY 7,259,166.98 in Q1 2021[19] - The total comprehensive income for the period was CNY 69,904,199.66, compared to a loss of CNY 4,831,566.98 in the previous period[20] Cash Flow - The net cash flow from operating activities was CNY 93,861,510.22, up 221.08% from a negative cash flow of CNY 77,519,542.59 in the same period last year[3] - The net cash flow from operating activities was CNY 93,861,510.22, a significant improvement from a negative cash flow of CNY 77,519,542.59 in the previous period[23] - Cash received from the sale of goods and services amounted to CNY 614,483,687.43, up from CNY 467,168,199.66 in the previous period, representing a growth of approximately 31.5%[22] - The net cash flow from investing activities was negative at CNY 101,770,882.66, an improvement from a larger negative cash flow of CNY 238,370,333.44 in the previous period[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 6,950,443,527.16, a 2.07% increase from CNY 6,809,728,251.24 at the end of the previous year[3] - Total assets as of March 31, 2022, amounted to CNY 6,950,443,527.16, up from CNY 6,809,728,251.24 at the start of the year[16] - The total liabilities increased slightly to CNY 4,777,739,297.26 from CNY 4,728,577,937.62, showing a stable leverage position[16] Equity and Retained Earnings - The total equity attributable to shareholders increased to CNY 1,368,049,246.68, a 6.19% rise from CNY 1,288,301,089.98 at the end of the previous year[3] - The total equity attributable to shareholders increased to CNY 1,368,049,246.68 from CNY 1,288,301,089.98, reflecting strong retained earnings growth[16] Research and Development - The company's R&D expenses increased by CNY 3,499,600, a 43.73% rise compared to the same period last year, due to lower spending in the previous year caused by the COVID-19 pandemic[7] - Research and development expenses rose to CNY 11,501,411.09 from CNY 8,001,828.21, highlighting the company's commitment to innovation[19] Other Income and Expenses - The company reported a significant increase in other income, totaling CNY 9,477,197.11 compared to CNY 3,567,194.66 in the previous year[19] - Operating costs for the same period were CNY 682,102,513.46, up from CNY 532,367,474.08, reflecting a significant increase in operational expenses[18] Inventory and Supply Chain - The company’s inventory levels rose to CNY 289,709,416.30 from CNY 279,989,731.90, indicating a proactive approach to managing supply chain dynamics[14] Audit and Compliance - The company did not conduct an audit for the first quarter report[25]